<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>35(19-20)</volume><submitter>Zhou Y</submitter><pubmed_abstract>A potential therapeutic approach for cancer treatment is target oxidative phosphorylation and glycolysis simultaneously. The matrix protein of vesicular stomatitis virus (VSV MP) can target the surface of mitochondria, causing morphological changes that may be associated with mitochondrial dysfunction and oxidative phosphorylation inhibition. Previous research has shown that mitochondrial abnormalities can direct glucose metabolism toward glycolysis. Thus, after treatment with VSV MP, glycolysis inhibition is necessary to completely block glucose metabolism and eradicate cancer. Here, to inhibit glycolysis, the 2-deoxy-D-glucose (2-DG), a synthetic glucose analog was used to combine with VSV MP to treat cancer. This study aims to determine how VSV MP affects the glucose bioenergetic metabo</pubmed_abstract><journal>Human gene therapy</journal><pagination>838-854</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11511779</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma.</pubmed_title><pmcid>PMC11511779</pmcid><pubmed_authors>Mei K</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Chen P</pubmed_authors><pubmed_authors>Chenm J</pubmed_authors><pubmed_authors>Kang M</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma.</name><description>A potential therapeutic approach for cancer treatment is target oxidative phosphorylation and glycolysis simultaneously. The matrix protein of vesicular stomatitis virus (VSV MP) can target the surface of mitochondria, causing morphological changes that may be associated with mitochondrial dysfunction and oxidative phosphorylation inhibition. Previous research has shown that mitochondrial abnormalities can direct glucose metabolism toward glycolysis. Thus, after treatment with VSV MP, glycolysis inhibition is necessary to completely block glucose metabolism and eradicate cancer. Here, to inhibit glycolysis, the 2-deoxy-D-glucose (2-DG), a synthetic glucose analog was used to combine with VSV MP to treat cancer. This study aims to determine how VSV MP affects the glucose bioenergetic metabo</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-04T10:53:26.893Z</modification><creation>2026-05-08T03:10:31.06Z</creation></dates><accession>S-EPMC11511779</accession><cross_references><pubmed>39001830</pubmed><doi>10.1089/hum.2024.002</doi></cross_references></HashMap>